A detailed history of High Tower Advisors, LLC transactions in Prime Medicine, Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 21,675 shares of PRME stock, worth $69,360. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,675
Previous 22,234 2.51%
Holding current value
$69,360
Previous $114,000 27.19%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$3.41 - $6.7 $1,906 - $3,745
-559 Reduced 2.51%
21,675 $83,000
Q2 2024

Aug 13, 2024

SELL
$4.3 - $8.03 $223 - $417
-52 Reduced 0.23%
22,234 $114,000
Q1 2024

May 06, 2024

BUY
$6.35 - $9.39 $7,423 - $10,976
1,169 Added 5.54%
22,286 $156,000
Q4 2023

Feb 12, 2024

SELL
$5.59 - $9.55 $1,017 - $1,738
-182 Reduced 0.85%
21,117 $187,000
Q3 2023

Nov 08, 2023

SELL
$9.5 - $15.07 $218 - $346
-23 Reduced 0.11%
21,299 $203,000
Q2 2023

Aug 14, 2023

BUY
$11.41 - $17.05 $243,284 - $363,540
21,322 New
21,322 $312,000

Others Institutions Holding PRME

About Prime Medicine, Inc.


  • Ticker PRME
  • Shares Outstandng 95,730,200
  • Market Cap $306M
More about PRME
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.